FDA issued a Warning Letter to Sovereign Pharmaceuticals, LLC on 01/29/2013 for a later inspection.
483 Sovereign Pharmaceuticals Sep 2001

483 Sovereign Pharmaceuticals Sep 2001

David Beltran FDA$595.00 - Available Now

FDA investigators audited the Sovereign Pharmaceuticals - Fort Worth, TX, United States facility and issued inspectional observations (via FDA 483) on 27 Sep 2001.

Product details

  • Category: Human Drugs
  • Inspection end: 27 Sep 2001
  • Location: Fort Worth, United States
  • FEI: 3003229412
Add To Cart